Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco Galaxy Bitcoin ETF (BTCO) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Invesco Galaxy Bitcoin ETFTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Invesco Galaxy Bitcoin ETF vs Neurocrine Biosciences Inc — how do they compare? Invesco Galaxy Bitcoin ETF trades at $63.05, while Neurocrine Biosciences Inc trades at $156.86 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

BTCONBIX
Sector
Crypto-linkedHealth
52-Week High
$125.14$185.50
52-Week Low
$58.40$123.10
Market Cap
$16.46B
Enterprise Value
$16.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco Galaxy Bitcoin ETF

No Aura AI signal available yet.

Neurocrine Biosciences Inc

Neurocrine Biosciences (NBIX) trades at $158.89, down 3.66% in the past 24 hours, reflecting near-term bearish technical signals. The stock shows strong fundamentals with Q2 2026 revenue growth of 39% year-over-year to $959 million and a net income margin of 20.91%. Recent news highlights include positive clinical data for INGREZZA and the initiation of a Phase 1 study for a GLP-1/GIP/glucagon receptor triple agonist, though safety concerns were raised for Vykat XR in Prader-Willi Syndrome.

The outlook remains positive given robust earnings beats, raised 2026 sales guidance, and a consensus price target of $208.82 implying significant upside. Risks include clinical trial setbacks, competitive pressures, and regulatory scrutiny. Analyst sentiment is strongly bullish with 86% buy ratings, supporting a growth-oriented investment case amid near-term volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Invesco Galaxy Bitcoin ETF

BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.

Read more on BTCO

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX